Protein Kinase CK2 Controls CD8+ T Cell Effector and Memory Function during Infection
暂无分享,去创建一个
Wei Yang | L. Harrington | E. Benveniste | Jianhua Zhang | V. Darley-Usmar | Xiaosen Ouyang | G. Benavides | Hairong Wei | H. Qin | W. Turbitt | Jessica A Buckley | Lianna Zhou | L. Zhou | Jessica A. Buckley | Lianna Zhou
[1] M. Ruzzene,et al. Protein kinase CK2 inhibition as a pharmacological strategy. , 2021, Advances in protein chemistry and structural biology.
[2] L. Lenz,et al. Myeloid Cell CK2 Regulates Inflammation and Resistance to Bacterial Infection , 2020, Frontiers in Immunology.
[3] K. Husain,et al. Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer , 2020, Immunological medicine.
[4] Andrew R. Leach,et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection , 2020, Cell.
[5] J. Tapia,et al. Protein Kinase CK2 in Cancer Energetics , 2020, Frontiers in Oncology.
[6] Wei Yang,et al. Protein Kinase 2 (CK2) Controls CD4+ T-cell Effector Function in the Pathogenesis of Colitis , 2020, Mucosal Immunology.
[7] Wei Yang,et al. CK2 Controls Th17 and Regulatory T Cell Differentiation Through Inhibition of FoxO1 , 2018, The Journal of Immunology.
[8] E. Benveniste,et al. Protein Kinase CK2: An Emerging Regulator of Immunity. , 2018, Trends in immunology.
[9] M. Mittelbrunn,et al. Mitochondrial activity in T cells. , 2017, Mitochondrion.
[10] P. Romero,et al. Metabolic Control of CD8+ T Cell Fate Decisions and Antitumor Immunity. , 2018, Trends in molecular medicine.
[11] Wei Yang,et al. Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation , 2017, The Journal of Immunology.
[12] L. Harrington,et al. IL-2 producing and non-producing effector CD8 T cells phenotypically and transcriptionally coalesce to form memory subsets with similar protective properties. , 2017 .
[13] A. Toker,et al. AKT/PKB Signaling: Navigating the Network , 2017, Cell.
[14] J. Auwerx,et al. Analysis of mtDNA/nDNA Ratio in Mice , 2017, Current protocols in mouse biology.
[15] T. Sparwasser,et al. Metabolic pathways in T cell activation and lineage differentiation. , 2016, Seminars in immunology.
[16] H. Schild,et al. Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development , 2016, Proceedings of the National Academy of Sciences.
[17] M. Buck,et al. T cell metabolism drives immunity , 2015, The Journal of experimental medicine.
[18] H. Schild,et al. Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo , 2015, Nature Immunology.
[19] Jonathan D. Powell,et al. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses , 2014, Nature Reviews Immunology.
[20] Michael Q. Zhang,et al. The transcription factor Foxo1 controls central-memory CD8+ T cell responses to infection. , 2013, Immunity.
[21] B. Faubert,et al. Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis , 2013, Cell.
[22] E. Yang,et al. Transcriptional insights into the CD8+ T cell response to infection and memory T cell formation , 2013, Nature Immunology.
[23] J. Lancaster,et al. Integration of cellular bioenergetics with mitochondrial quality control and autophagy , 2012, Biological chemistry.
[24] Susan M. Kaech,et al. Transcriptional control of effector and memory CD8+ T cell differentiation , 2012, Nature Reviews Immunology.
[25] Hongbo Chi,et al. Regulation and function of mTOR signalling in T cell fate decisions , 2012, Nature Reviews Immunology.
[26] D. Green,et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.
[27] E. Yang,et al. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets , 2011, Nature Immunology.
[28] A. Landar,et al. Assessing bioenergetic function in response to oxidative stress by metabolic profiling. , 2011, Free radical biology & medicine.
[29] Michael J. Bevan,et al. CD8+ T Cells: Foot Soldiers of the Immune System , 2011, Immunity.
[30] S. Nutt,et al. Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. , 2009, Immunity.
[31] D. Seldin,et al. Protein Kinase CK2 in Health and Disease , 2009, Cellular and Molecular Life Sciences.
[32] D. Ramji,et al. Protein kinase CK2, an important regulator of the inflammatory response? , 2008, Journal of Molecular Medicine.
[33] L. Harrington,et al. Memory CD4 T cells emerge from effector T-cell progenitors , 2008, Nature.
[34] James S. Duncan,et al. Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. , 2008, Biochimica et biophysica acta.
[35] Nikhil S. Joshi,et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. , 2007, Immunity.
[36] M. Bevan,et al. Effector and memory CTL differentiation. , 2007, Annual review of immunology.
[37] A. Goldrath,et al. Transcriptional regulator Id2 mediates CD8+ T cell immunity , 2006, Nature Immunology.
[38] E. Wherry,et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin , 2005, Nature Immunology.
[39] T. Tokuhisa,et al. Bcl6 Acts as an Amplifier for the Generation and Proliferative Capacity of Central Memory CD8+ T Cells1 , 2004, The Journal of Immunology.
[40] E. Wherry,et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells , 2003, Nature Immunology.
[41] D. Litchfield. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. , 2003, The Biochemical journal.
[42] David Gray,et al. Immunological Memory and Protective Immunity: Understanding Their Relation , 1996, Science.
[43] Kristin A. Hogquist,et al. T cell receptor antagonist peptides induce positive selection , 1994, Cell.